Over-Regulation Is Damaging French Pharma Sector

Industry claims government is reneging on its commitments

Leem says “Inconsistent and unpredictable” policies are hitting industry’s competitiveness and limiting patients’ access to new medicines.

SC1810_Pruning_625931555_1200.jpg
Industry says French cuts are limiting its ability to flourish

More from France

More from Europe